A GLP‐1/glucagon (GCG)/CCK <sub>2</sub> receptors tri‐agonist provides new therapy for obesity and diabetes-Reference-Cited by-同舟云学术

A GLP‐1/glucagon (GCG)/CCK ₂ receptors tri‐agonist provides new therapy for obesity and diabetes

Published:2022-05-20 Issue:17 Volume:179 Page:4360-4377
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British J Pharmacology

Author:

Zhao Songfeng¹,Yan Zhiming²,Du Yue¹,Li Zeyun¹,Tang Chunli³,Jing Lin³,Sun Lidan⁴,Yang Qimeng⁴,Tang Xueling⁴,Yuan Yongliang¹,Han Jing⁴^ORCID,Jiang Neng³

Affiliation:

1. Department of Pharmacology The First Affiliated Hospital of Zhengzhou University Zhengzhou People's Republic of China

2. Pharmaceutical College Guangxi Medical University Nanning People's Republic of China

3. Department of Pharmacy Guangxi Medical University Cancer Hospital Nanning People's Republic of China

4. School of Chemistry & Materials Science Jiangsu Normal University Xuzhou People's Republic of China

Funder

National Natural Science Foundation of China

Basic Public Welfare Research Program of Zhejiang Province

Youth Science Foundation of Guangxi Medical University

Specific Research Project of Guangxi for Research Bases and Talents

Science Fund for Distinguished Young Scholars of Guangxi Province

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15860

Reference47 articles.

1. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors

2. Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology

3. Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study

4. New CCK2 agonists confirming the heterogeneity of CCK2 receptors: characterisation of BBL454

5. Type 2 diabetes

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5;Advanced Science;2024-08-19

2. Discovery of novel glucagon-like peptide 1/cholecystokinin 1 receptor dual agonists;European Journal of Pharmaceutical Sciences;2024-08

3. Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy;International Journal of Molecular Sciences;2024-07-27

4. Glucagon-like peptide-1 analogs: Miracle drugs are blooming?;European Journal of Medicinal Chemistry;2024-04

5. The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update;Endocrinology and Metabolism;2024-02-29